Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease

Expert Opinion on Drug Metabolism and Toxicology

Volumn 5, Issue 9, 2009, Pages 1049-1063

  Mo, Wei ^b   Zhang, Jian Ting ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

ABC transporter; Dimers; Multi drug resistance; Oligomerization

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; COLCHICINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLAVOPIRIDOL; METHOTREXATE; MITOXANTRONE; PACLITAXEL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

CELL MEMBRANE TRANSPORT; CYSTIC FIBROSIS; HUMAN; HYDROLYSIS; MULTIDRUG RESISTANCE; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; DISEASE; DRUG RESISTANCE, MULTIPLE; HUMANS; PROTEIN MULTIMERIZATION;

EID: 70249099233     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425250903124371     Document Type: Review

References (102)

1. Hollenstein K, Dawson RJ, Locher KP. Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 2007;17(4):412-418 (Pubitemid 47451766)
2. Linton KJ. Structure and function of ABC transporters. Physiology (Bethesda) 2007;22:122-30 •• Comprehensive review of ABC transporters structure and detailed explanation of ATP-switch mechanism powering transporter functions.
3. Szakacs G, Paterson JK, Ludwig JA, et al. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006;5(3):219-234
4. Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist 2003;8(5):411-424 (Pubitemid 37238869)
5. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004;1(1):27-42
6. Dano K. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor invivo. Cancer Chemother Rep 1972;56(6):701-708
7. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 1973;323(3):466-483
8. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455(1):152-62 •• Discovery of ABCB1 and its significance in regulating drug transport.
9. Linton KJ, Higgins CF. Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch 2007;453(5):555-567
10. Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982;1(8):945-951
11. Dawson RJ, Hollenstein K, Locher KP. Uptake or extrusion: crystal structures of full ABC transporters suggest a common mechanism. Mol Microbiol 2007;65(2):250-257 (Pubitemid 47052721)
12. Yang Y, Liu Y, Dong Z, etal. Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1. J Biol Chem 2007;282(12):8821-30 •• Dimerization domain of human ABCC1 was demonstrated. (Pubitemid 47093510)
13. Tabcharani JA, Chang XB, Riordan JR, Hanrahan JW. Phosphorylation- regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature 1991;352(6336):628-631 (Pubitemid 21912395)
14. Inagaki N, Gonoi T, Clement JPT, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270(5239):1166-1170
15. Chen ZQ, Dong J, Ishimura A, et al. The essential vertebrate ABCE1 protein interacts with eukaryotic initiation factors. J Biol Chem 2006;281(11):7452-7457 (Pubitemid 43847517)
16. Kerr ID. Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition. Biochem Biophys Res Commun 2004;315(1):166-173
17. Gao M, Loe DW, Grant CE, et al. Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells. J Biol Chem 1996;271(44):27782- 27787 (Pubitemid 26367352)
18. Ostedgaard LS, Rich DP, DeBerg LG, Welsh MJ. Association of domains within the cystic fibrosis transmembrane conductance regulator. Biochemistry 1997;36(6):1287-1294 (Pubitemid 27074952)
19. Gauthier C, Weber S, Alarco AM, et al. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob Agents Chemother 2003;47(5):1543-1554 (Pubitemid 36548535)
20. Herget M, Tampe R. Intracellular peptide transporters in human-compartmentalization of the "peptidome". Pflugers Arch 2007;453(5):591-600
21. Arnold D, Driscoll J, Androlewicz M, et al. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 1992;360(6400):171-174
22. Androlewicz MJ, Ortmann B, van Endert PM, etal. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc Natl Acad Sci USA 1994;91(26):12716-12720
23. Spies T, Cerundolo V, Colonna M, et al. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 1992;355(6361):644-646
24. Lacaille VG, Androlewicz MJ. Herpes simplex virus inhibitor ICP47 destabilizes the transporter associated with antigen processing (TAP) heterodimer. J Biol Chem 1998;273(28):17386-17390
25. Ortmann B, Copeman J, Lehner PJ, et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997;277(5330):1306-1309 (Pubitemid 27449083)
26. Meyer TH, van Endert PM, Uebel S, et al. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett 1994;351(3):443-447
27. Velarde G, Ford RC, Rosenberg MF, Powis SJ. Three-dimensional structure of transporter associated with antigen processing (TAP) obtained by single Particle image analysis. J Biol Chem 2001;276(49):46054-46063 (Pubitemid 37370853)
28. Ohara T, Ohashi-Kobayashi A, Maeda M. Biochemical characterization of transporter associated with antigen processing (TAP)-like (ABCB9) expressed in insect cells. Biol Pharm Bull 2008;31(1):1-5
29. Graf GA, Yu L, Li WP, etal. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 2003;278(48):48275-48282 (Pubitemid 37523283)
30. Graf GA, Li WP, Gerard RD, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002;110(5):659-669
31. Graf GA, Cohen JC, Hobbs HH. Missense mutations in ABCG5 and ABCG8 disrupt heterodimerization and trafficking. J Biol Chem 2004;279(23):24881-24888
32. Wang J, Zhang DW, Lei Y, et al. Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8. Biochemistry 2008;47(18):5194-5204 (Pubitemid 351620756)
33. Zhang DW, Graf GA, Gerard RD, et al. Functional asymmetry of nucleotide-binding domains in ABCG5 and ABCG8. J Biol Chem 2006;281(7):4507-4516
34. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998;95(26):15665-70 • Discovery of human ABCG2 and its relationship with multi-drug resistance. (Pubitemid 29018757)
35. Xu J, Peng H, Zhang JT. Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy. Curr Med Chem 2007;14(6):689-701 (Pubitemid 46477721)
36. Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 2003;52(12):1788-1795 (Pubitemid 37510405)
37. Zhang JT. Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007;32(4):531-541
38. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol2006;46:381-410
39. Candeil L, Gourdier I, Peyron D, et al. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer 2004;109(6):848-854 (Pubitemid 38500741)
40. Kage K, Tsukahara S, Sugiyama T, et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 2002;97(5):626-630 (Pubitemid 34087801)
41. Bhatia A, Schafer HJ, Hrycyna CA. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers. Biochemistry 2005;44(32):10893-10904 (Pubitemid 41153650)
42. Henriksen U, Fog JU, Litman T, Gether U. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J Biol Chem 2005;280(44):36926-36934 (Pubitemid 41587775)
43. Liu Y, Yang Y, Qi J, etal. Effect of cysteine mutagenesis on the functionand disulfide bond formation of human ABCG2. J Pharmacol Exp Ther 2008;326(1):33-40 (Pubitemid 351872136)
44. Liu LX, Janvier K, Berteaux-Lecellier V, et al. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem 1999;274(46):32738-32743 (Pubitemid 129535304)
45. Hillebrand M, Verrier SE, Ohlenbusch A, et al. Live cell FRET microscopy: homo- and heterodimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3). J Biol Chem 2007;282(37):26997-27005 (Pubitemid 47501958)
46. Guimaraes CP, Domingues P, Aubourg P, et al. Mouse liver PMP70 and ALDP: homomeric interactions prevail invivo. Biochim Biophys Acta 2004;1689(3):235-243 (Pubitemid 38981601)
47. Kashiwayama Y, Morita M, Kamijo K, Imanaka T. Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes. Biochem Biophys Res Commun 2002;291(5):1245-1251 (Pubitemid 34694323)
48. Wanders RJ, Visser WF, van Roermund CW, etal. The peroxisomal ABC transporter family. Pflugers Arch 2007;453(5):719-734
49. Litman T, Jensen U, Hansen A, et al. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim Biophys Acta 2002;1565(1):6-16 (Pubitemid 35239827)
50. Xu J, Liu Y, Yang Y, etal. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 2004;279(19):19781-9 • The existence of human ABCG2 oligomer was shown with a proposed 12-subunit model. (Pubitemid 38623417)
51. McDevitt CA, Collins RF, Conway M, et al. Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. Structure 2006;14(11):1623-1632 (Pubitemid 46107268)
52. Xu J, Peng H, Chen Q, et al. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity. Cancer Res 2007;67(9):4373-4381 (Pubitemid 46815086)
53. Kaminski WE, Piehler A, Wenzel JJ. ABC A-subfamily transporters: structure, function and disease. Biochim Biophys Acta 2006;1762(5):510-524
54. Denis M, Haidar B, Marcil M, et al. Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles. J Biol Chem 2004;279(40):41529-41536 (Pubitemid 39313594)
55. Trompier D, Alibert M, Davanture S, et al. Transition from dimers to higher oligomeric forms occurs during the ATPase cycle of the ABCA1 transporter. J Biol Chem 2006;281(29):20283-90 •• The authors demonstrated ABCA1 oligomeriztion and proposed a model in which ABC transporters may have another level of regulation of function by having different oligomeric status. (Pubitemid 44065803)
56. Hozoji M, Kimura Y, Kioka N, Ueda K. Formation of two intramolecular disulfide bonds is necessary for apoA-I-dependent cholesterol efflux mediated by ABCA1. J Biol Chem 2009;284(17):11293-11300
57. Buechler C, Boettcher A, Bared SM, et al. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem Biophys Res Commun 2002;293(2):759-765 (Pubitemid 34687253)
58. Fitzgerald ML, Okuhira K, Short GF 3rd, et al. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J Biol Chem 2004;279(46):48477-48485 (Pubitemid 39541006)
59. Al-Shawi MK, Omote H. The remarkable transport mechanism of P-glycoprotein: a multidrug transporter. J Bioenerg Biomembr 2005;37(6):489-496 (Pubitemid 43725181)
60. Boscoboinik D, Debanne MT, Stafford AR, et al. Dimerization of the P-glycoprotein in membranes. Biochim Biophys Acta 1990;1027(3):225-228
61. Jette L, Potier M, Beliveau R. P-glycoprotein is a dimer in the kidney and brain capillary membranes: effect of cyclosporin A and SDZ-PSC 833. Biochemistry 1997;36(45):13929-13937 (Pubitemid 27494901)
62. Naito M, Tsuruo T. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells. Biochem Biophys Res Commun 1992;185(1):284-290
63. Poruchynsky MS, Ling V. Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells. Biochemistry 1994;33(14):4163-4174 (Pubitemid 24140600)
64. Taylor JC, Horvath AR, Higgins CF, Begley GS. The multidrug resistance P-glycoprotein. Oligomeric state and intramolecular interactions. J Biol Chem 2001;276(39):36075-36078 (Pubitemid 37384207)
65. Rosenberg MF, Callaghan R, Ford RC, Higgins CF. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem 1997;272(16):10685-10694 (Pubitemid 27181079)
66. Aller SG, Yu J, Ward A, etal. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009;323(5922):1718-22 •• Crystal structure of mouse ABCB1 was shown.
67. Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258(5088):1650-1654 (Pubitemid 23012438)
68. Ishikawa T, Kuo MT, Furuta K, Suzuki M. The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design. Clin Chem Lab Med 2000;38(9):893-897 (Pubitemid 30814772)
69. Soszynski M, Kaluzna A, Rychlik B, et al. Radiation inactivation suggests that human multidrug resistance-associated protein 1 occurs as a dimer in the human erythrocyte membrane. Arch Biochem Biophys 1998;354(2):311-316 (Pubitemid 28373982)
70. Rosenberg MF, Mao Q, Holzenburg A, et al. The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis. J Biol Chem 2001;276(19):16076-16082 (Pubitemid 37391646)
71. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79(Suppl 1):S23-45
72. Ramjeesingh M, Kidd JF, Huan LJ, et al. Dimeric cystic fibrosis transmembrane conductance regulator exists in the plasma membrane. Biochem J 2003;374(Pt 3):793-797 (Pubitemid 37163927)
73. Schillers H, Shahin V, Albermann L, et al. Imaging CFTR: a tail to tail dimer with a central pore. Cell Physiol Biochem 2004;14(1-2):1-10 (Pubitemid 38269818)
74. Eskandari S, Wright EM, Kreman M, etal. Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy. Proc Natl Acad Sci USA 1998;95(19):11235-11240
75. Zerhusen B, Zhao J, Xie J, etal. A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. J Biol Chem 1999;274(12):7627-7630 (Pubitemid 129518146)
76. Wang S, Yue H, Derin RB, etal. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 2000;103(1):169-79 •• Evidence indicates chaperone might play a role in modulating ABC transporter functions through regulating transporter's oligomerization status.
77. Gupta S, Xie J, Ma J, Davis PB. Intermolecular interaction between R domains of cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol 2004;30(2):242-248 (Pubitemid 38147210)
78. Rosenberg MF, Kamis AB, Aleksandrov LA, et al. Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 2004;279(37):39051-39057 (Pubitemid 39296067)
79. Haggie PM, Verkman AS. Monomeric CFTR in plasma membranes in live cells revealed by single molecule fluorescence imaging. J Biol Chem 2008;283(35):23510-23513
80. Seddon AM, Curnow P, Booth PJ. Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 2004;1666(1-2):105-117 (Pubitemid 39425201)
81. Verkman AS, Skorecki K, Ausiello DA. Radiation inactivation of oligomeric enzyme systems: theoretical considerations. Proc Natl Acad Sci USA 1984;81(1):150-154 (Pubitemid 14180845)
82. Das M, Fox CF. Chemical cross-linking in biology. Annu Rev Biophys Bioeng 1979;8:165-193
83. Sinz A. Chemical cross-linking and mass spectrometry to map three-dimensional protein structures and protein-protein interactions. Mass Spectrom Rev 2006;25(4):663-82 • Detailed introduction of chemical crosslinking followed by mass spectrometry and its advantage in demonstrating low-resolution membrane protein-protein interaction. (Pubitemid 44014105)
84. Ciruela F. Fluorescence-based methods in the study of protein-protein interactions in living cells. Curr Opin Biotechnol 2008;19(4):338-343
85. Rai M, Padh H. Expression systems for production of heterologous proteins.Curr Sci 2001;80(9):1121-1128
86. Ahmad S, Safa AR, Glazer RI. Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry 1994;33(34):10313-10318 (Pubitemid 24281796)
87. Partridge AW, Melnyk RA, Yang D, et al. A transmembrane segment mimic derived from Escherichia coli diacylglycerol kinase inhibits protein activity. J Biol Chem 2003;278(24):22056-22060 (Pubitemid 36792615)
88. Peelman F, Labeur C, Vanloo B, et al. Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology. J Mol Biol 2003;325(2):259-274 (Pubitemid 36062687)
89. Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 2007;453(5):601-610
90. Frank NY, Pendse SS, Lapchak PH, et al. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 2003;278(47):47156-47165
91. Arrese M, Ananthanarayanan M. The bile salt export pump: molecular properties, function and regulation. Pflugers Arch 2004;449(2):123-131
92. Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004;5(1):21-53 (Pubitemid 38294344)
93. Bryan J, Munoz A, Zhang X, etal. ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch 2007;453(5):703-718
94. Abele R, Tampe R. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 2004;19:216-224 (Pubitemid 39481937)
95. Kurashima-Ito K, Ikeya T, Senbongi H, et al. Heteronuclear multidimensional NMR and homology modelling studies of the C-terminal nucleotide-binding domain of the human mitochondrial ABC transporter ABCB6. J Biomol NMR 2006;35(1):53-71 (Pubitemid 43941722)
96. Csere P, Lill R, Kispal G. Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p. FEBS Lett 1998;441(2):266-270 (Pubitemid 29027908)
97. Hogue DL, Liu L, Ling V. Identification and characterization of a mammalian mitochondrial ATP-binding cassette membrane protein. J Mol Biol 1999;285(1):379-389 (Pubitemid 29034051)
98. Kamakura A, Fujimoto Y, Motohashi Y, et al. Functional dissection of transmembrane domains of human TAP-like (ABCB9). Biochem Biophys Res Commun 2008;377(3):847-851
99. Zhang F, Hogue DL, Liu L, et al. M-ABC2, a new human mitochondrial ATP-binding cassette membrane protein. FEBS Lett 2000;478(1-2):89-94 (Pubitemid 30462264)
100. Kusuhara H, Sugiyama Y. ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch 2007;453(5):735-744
101. Barthelme D, Scheele U, Dinkelaker S, et al. Structural organization of essential iron-sulfur clusters in the evolutionarily highly conserved ATP-binding cassette protein ABCE1. J Biol Chem 2007;282(19):14598-14607 (Pubitemid 47100438)
102. Richard M, Drouin R, Beaulieu AD. ABC50, a novel human ATP-binding cassette protein found in tumor necrosis factor-alpha-stimulated synoviocytes. Genomics 1998;53(2):137-145 (Pubitemid 28496603)